Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Shares Issued (2020 - 2023)

Maravai Lifesciences Holdings has reported Shares Issued over the past 4 years, most recently at $312000.0 for Q3 2023.

  • Quarterly results put Shares Issued at $312000.0 for Q3 2023, down 57.26% from a year ago — trailing twelve months through Sep 2023 was $1.9 million (down 18.08% YoY), and the annual figure for FY2022 was $2.4 million, up 37.98%.
  • Shares Issued for Q3 2023 was $312000.0 at Maravai Lifesciences Holdings, down from $365000.0 in the prior quarter.
  • Over the last five years, Shares Issued for MRVI hit a ceiling of $730000.0 in Q3 2022 and a floor of $311000.0 in Q3 2021.
  • Median Shares Issued over the past 4 years was $414000.0 (2021), compared with a mean of $470000.0.
  • Biggest five-year swings in Shares Issued: surged 134.73% in 2022 and later tumbled 57.26% in 2023.
  • Maravai Lifesciences Holdings' Shares Issued stood at $321000.0 in 2020, then increased by 18.38% to $380000.0 in 2021, then fell by 3.95% to $365000.0 in 2022, then decreased by 14.52% to $312000.0 in 2023.
  • The last three reported values for Shares Issued were $312000.0 (Q3 2023), $365000.0 (Q4 2022), and $730000.0 (Q3 2022) per Business Quant data.